Prothrombotic gene polymorphisms and atherothrombotic cerebral infarction (Q28187014)

2

0 references

J Kobal

3

0 references

D Bregar

4

0 references

K P Potisk

5

0 references

B Peterlin

Acta Neurologica Scandinavica

6

0 references

language of work or name

English

0 references

publication date

August 2003

0 references

published in

0 references

volume

108

0 references

issue

2

0 references

page(s)

109-13

0 references

cites work

Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00126.X

Stroke incidence and mortality correlated to stroke risk factors in the WHO MONICA Project. An ecological study of 18 populations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00126.X

Metabolic determinants are much more important than genetic polymorphisms in determining the PAI-1 activity and antigen plasma concentrations: a family study with part of the Stanislas Cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00126.X

Mutation in blood coagulation factor V associated with resistance to activated protein C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00126.X

Activated protein C resistance in ischemic stroke not due to factor V arginine506-->glutamine mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00126.X

Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00126.X

[Hereditary thrombophilia with ischemiC stroke and sinus thrombosis. Diagnosis, therapy and meta-analysis]

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00126.X

Polymorphisms of the factor VII gene and circulating FVII:C levels in relation to acute cerebrovascular disease and poststroke mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00126.X

Gene polymorphisms predicting high plasma levels of coagulation and fibrinolysis proteins. A study in centenarians.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00126.X

4G/5G polymorphism of the plasminogen activator inhibitor-1 gene and insertion/deletion polymorphism of the tissue-type plasminogen activator gene in atherothrombotic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00126.X

Arterial and venous thrombosis is not associated with the 4G/5G polymorphism in the promoter of the plasminogen activator inhibitor gene in a large cohort of US men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00126.X

C677T MTHFR mutation and factor V Leiden mutation in patients with TIA/minor stroke: a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00126.X

Joint effect of G1691A factor V point mutation and factor VII Arg/Gln(353) gene polymorphism on the risk of premature coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00126.X

The 4G/4G genotype at nucleotide position -675 in the promotor region of the plasminogen activator inhibitor 1 (PAI-1) gene is less frequent in young patients with minor stroke than in controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00126.X

The Barcelona Stroke Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00126.X

Tissue plasminogen activator, plasminogen activator inhibitor-1, and tissue plasminogen activator/plasminogen activator inhibitor-1 complex as risk factors for the development of a first stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00126.X

Plasminogen activator inhibitor 4G polymorphism is associated with decreased risk of cerebrovascular mortality in older women

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00126.X

Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00126.X

A common genetic polymorphism associated with lower coagulation factor VII levels in healthy individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00126.X

Are there any associations among coagulation factor VII gene polymorphism, plasma activated factor VII levels, and cerebrovascular disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00126.X

Blindness among nursing home residents

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00126.X

Diabetes and cardiovascular disease. The Framingham study

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00126.X

7 January 2021

Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00126.X

7 January 2021

Genetic and environmental determinants of factor VII coagulant activity in ethnic groups at differing risk of coronary heart disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00126.X

7 January 2021

Factor VII R353Q polymorphism and lacunar stroke in Japanese hypertensive patients and normotensive controls.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2003.00126.X

7 January 2021